News Search Results
Mar 11, 2025, 08:00 ET Apnimed Appoints Kevin R. Lind as Non-Executive Chairman of the Board of Directors
Kevin to Apnimed's Board," said Larry Miller, MD, Chief Executive Officer of Apnimed. "His proven leadership in biotechnology and corporate strategy will provide invaluable insights as we approach Phase 3 clinical trial results for AD109 and prepare for its potential commercial
More news about: Apnimed, Inc.
Mar 11, 2025, 07:00 ET Armata Pharmaceuticals Announces that CEO Dr. Deborah Birx Will Deliver a Presentation at the 7th Annual Bacteriophage Therapy Summit
March 11, 2025 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat
More news about: Armata Pharmaceuticals, Inc.
Mar 11, 2025, 06:59 ET Q32 Bio Reports Fourth Quarter 2024 Financial Results and Provides Corporate Update
March 11, 2025 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, today reported financial results for the quarter ended
More news about: Q32 Bio
Mar 10, 2025, 16:00 ET Protecting Women's Health: Visionary's Precision Cervical Cancer Screening Public Welfare Activity Brings Health Blessings to Women
USA, Inc., and co-organized by Yiqijia Group Co., Ltd. and (Canada) Visionary Biotechnology Group, etc. The attending guests included Hong Kong Councilors Hung Kam-in and Kan Ming-tung, Chairman of
More news about: Visionary Holdings Inc
Mar 10, 2025, 15:53 ET Christopher Wurster Joins Rubin and Rudman's Labor & Employment Group
Rubin and Rudman serves national and international companies, including large public companies and closely held businesses; real estate developers; biotechnology, pharmaceutical and medical device makers; regulated industries, public entities and municipalities; insurance companies and their insureds; educational
More news about: Rubin and Rudman
Mar 10, 2025, 15:02 ET Syngene Acquires its First Manufacturing Facility in the US
NSE: SYNGENE, ISIN: INE 398R01022) is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. Syngene's more than 5600 scientists offer both skills and the capacity
More news about: Syngene International
Mar 10, 2025, 11:29 ET Flagship Pioneering Unveils Lila Sciences to Build Superintelligence in Science
Sana Biotechnology (NASDAQ: SANA),
More news about: Flagship Pioneering
Mar 10, 2025, 11:00 ET TCI Biotech Announces Strong 2024 Financial Performance, Sets Sights on Global Growth in 2025
March 10, 2025 /PRNewswire/ -- TCI Biotech (TCI Co., Ltd.) (TWSE: 8436), a leading CDMO+ innovator in health food and skincare biotechnology, has released its consolidated financial results for the fiscal year ending December 31, 2024. The company reported
More news about: TCI; TCI Bio
Mar 10, 2025, 10:00 ET Daelight Solutions Achieves Veeva Premier Services Partner Level for Veeva Development Cloud
Solutions' continued commitment to providing exceptional services and expertise for Veeva's cloud-based software, empowering pharmaceutical and biotechnology organizations to optimize their operations and accelerate innovation.
More news about: Daelight Solutions
Mar 10, 2025, 09:13 ET FDA Accepts Biologics License Application for Duchenne Muscular Dystrophy Cardiomyopathy Treatment
wespeakduchenne.com. About Capricor Therapeutics, Inc.Capricor (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapeutics to redefine the treatment landscape for rare diseases. Capricor
More news about: NS Pharma, Inc.
Mar 10, 2025, 09:03 ET Growing Matters' BeSure! Campaign Returns to Promote Good Stewardship Practices This Season
the United States. CropLife America's member companies produce, sell, and distribute virtually all the necessary and vital pesticide and biotechnology products used by American farmers.
More news about: Growing Matters
Mar 10, 2025, 08:53 ET Reduction of Chemotherapy Associated Accelerated Aging by ImmortaSome™ Personalized Exosome Rejuvenation
provides means of reducing side effects of cancer therapies, as well as potentially will be applicable to aging caused by other means. "As a biotechnology corporation we need to identify as quickly as possible the therapeutic potency of our products," said Dr. Boris Reznik,
More news about: Immorta Bio Inc.
Mar 10, 2025, 08:30 ET Anixa Biosciences 2025 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it will host its 2025 Annual Meeting of Stockholders (the "Meeting")
More news about: Anixa Biosciences, Inc.
Mar 10, 2025, 08:05 ET Rigel Appoints Mark W. Frohlich, M.D. to Board of Directors
development pipeline and grow our portfolio." Dr. Frohlich currently serves as chief executive officer of Indapta Therapeutics, a privately-held biotechnology company focused on developing and bringing to market allogenic natural killer cell therapies to treat the still unmet medical needs of patients
More news about: Rigel Pharmaceuticals, Inc.
Mar 10, 2025, 07:30 ET Versatope Adds New Board Members
Mass., March 10, 2025 /PRNewswire/ -- Versatope Therapeutics Incorporated, a biotechnology company developing vaccines and immuno-therapeutics announced today Edward Jordan and Sam
More news about: Versatope Therapeutics, Incorporated
Mar 10, 2025, 07:05 ET REGENXBIO Announces Presentations at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
available in the Publications section of REGENXBIO's website. ABOUT REGENXBIO Inc.REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the development
More news about: REGENXBIO Inc.
Mar 10, 2025, 07:00 ET NLS Pharmaceutics CEO Issues Letter to Shareholders
the dynamic biotechnology landscape, driving NLS Pharmaceutics toward a future of unparalleled success. As we embark on this exciting new chapter, we remain laser-focused on: Building an international, strong, well-balanced pipeline and top-notch biotechnology companyDelivering
More news about: NLS Pharmaceutics Ltd.
Mar 10, 2025, 05:45 ET The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of ICON Public Limited Company(ICLR) Shareholders
insufficient to shield the Company from the adverse effects of a significant market downturn; (c) the requests for proposals ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: The Gross Law Firm
Mar 10, 2025, 03:14 ET China's effort helping drive greener future
members from scientific and technological sectors are leading experts in new quality productive forces including big data, artificial intelligence, biotechnology and quantum technology. The members carry out consultations on the basis of investigations and research, including visits to factories, research
More news about: chinadaily.com.cn
Mar 10, 2025, 00:59 ET Kenox Pharmaceuticals Announces Strategic Collaboration with Lactiga to Advance Mucosal-Targeted Immunotherapy
[email protected] About Lactiga US, Inc.: Lactiga is a biotechnology company developing novel mucosal antibodies derived from human breastmilk to improve the lives of vulnerable and compromised populations. The company
More news about: Kenox Pharmaceuticals Inc.
Mar 09, 2025, 19:16 ET U.S. FDA approves Celltrion's OMLYCLO® (omalizumab-igec) as the first and only biosimilar with interchangeability designation referencing XOLAIR®
ZYMFENTRA® (infliximab-dyyb). Celltrion USA will continue to leverage Celltrion's unique heritage in biotechnology, supply chain excellence and best-in-class sales capabilities to improve access to high-quality biopharmaceuticals for U.S. patients. For more information,
More news about: Celltrion
Mar 08, 2025, 13:00 ET Lilly's baricitinib delivered high rates of hair regrowth for adolescents with severe alopecia areata in Phase 3 BRAVE-AA-PEDS study
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Mar 08, 2025, 11:00 ET Q32 Bio Presents Results from SIGNAL-AA Part A Clinical Trial Evaluating Bempikibart in Patients with Alopecia Areata at the 2025 American Academy of Dermatology Meeting
March 8, 2025 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, today announced additional results from Part A of its SIGNAL-AA
More news about: Q32 Bio
Mar 08, 2025, 09:24 ET ICLR Purchasers Have Opportunity to Lead ICON plc Securities Fraud Lawsuit
were insufficient to shield ICON from the adverse effects of a significant market downturn; (3) the requests for proposals ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus were not indicative of underlying client demand;
More news about: THE ROSEN LAW FIRM, P. A.
Mar 08, 2025, 07:33 ET Why the Global Cancer Market Could Surpass $900 Billion--And the Stocks Leading the Charge
treatment of patients with previously treated advanced neuroendocrine tumors." Cardiff Oncology, Inc. (NASDAQ: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, recently
More news about: USA News Group